BIRACETAM 25 TABLET

Product Description

BIRACETAM 25 TABLET is a clinically approved antiepileptic medication containing Brivaracetam 25 mg, designed to support the effective management of partial-onset seizures in patients with epilepsy. As a second-generation anticonvulsant, Brivaracetam acts rapidly and selectively on synaptic vesicle protein 2A (SV2A), helping to stabilize electrical activity in the brain.

Key Benefits:

• Effective seizure control in partial-onset epilepsy

• Rapid onset of action with improved brain penetration

• Favorable safety profile with fewer behavioral side effects compared to earlier generation antiepileptics

• Suitable for use as monotherapy or adjunctive therapy

Applications:

Primarily indicated for the treatment of epilepsy, BIRACETAM 25 is widely prescribed in neurology clinics and hospitals. It is recommended for both adult and pediatric patients (age as per prescribing guidelines), either as a standalone therapy or in combination with other anticonvulsants.

Target Audience:

This product is ideal for pharmaceutical distributors, hospital procurement departments, neurology-focused pharmacies, and medical retailers seeking reliable seizure management solutions. Available in bulk quantities for institutional supply and wholesale purchase.

Industry Keywords:

Brivaracetam tablets, anti-epileptic drug suppliers, seizure control medicine, BIRACETAM 25 manufacturers, neurological care pharmaceuticals, epilepsy treatment tablets, Brivaracetam exporters, CNS drug wholesalers, partial seizure medication.

Packaging:

Available in standard blister packs with secure secondary packaging for safe transportation and long shelf life. Custom bulk packaging options are available upon request.

Regulatory Compliance:

Manufactured in WHO-GMP and ISO-certified facilities, ensuring stringent quality control and regulatory compliance for domestic and international markets